300246SZSE
🚨 Material Event

Audit Report on Project Termination and Fund Reallocation for Raised Funds

Baolait Technology Co., Ltd.··7 pages

✨ AI Summary

This report details the termination of certain fundraising projects and the reallocation of remaining funds to working capital. The company aims to improve fund utilization efficiency and support daily operations. The decision was approved by the board and audit committee, pending shareholder approval.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Audit Report of Cosun Securities Co., Ltd. on Guangdong Baolight Medical Technology Co., Ltd. Regarding the Termination of Raised Capital Projects and the Reallocation of Remaining Raised Capital for Permanent Supplementation of Working Capital

Cosun Securities Co., Ltd. (hereinafter referred to as "Cosun Securities" or "Sponsor") as the sponsor of Guangdong Baolight Medical Technology Co., Ltd. (hereinafter referred to as "Baolight" or "the Company"), in accordance with relevant laws and regulations, has conducted a serious and prudent review of Baolight's raised capital projects termination, partial termination of raised capital projects, and the reallocation of remaining raised capital for permanent supplementation of working capital. The details are as follows:

I. Basic Situation of Raised Capital

Upon approval by the China Securities Regulatory Commission's Document No. [2021] 3736 and with the consent of the Shenzhen Stock Exchange, the Company issued 28,723,404 ordinary shares to specific targets on January 17, 2022, at an issue price of RMB 18.80 per share, raising a total of RMB 539,999,995.20. After deducting issuance-related expenses (excluding tax), the net amount of raised capital was RMB 528,049,313.53.

As of January 25, 2022, the aforementioned raised capital had been fully received by the Company, as confirmed by the audit report No. "Dahua Audit [2022] 000055" issued by Dahua Certified Public Accountants (Special General Partnership).

After several adjustments, the utilization plan for the raised capital is as follows:

Project NameOriginal Total InvestmentAdjusted Total InvestmentOriginal Planned InvestmentAdjusted Planned InvestmentCurrent Progress
Baolight Hemodialysis Industry Base and R&D Center Project43,890.0266,877.5224,500.0035,500.00Project completed
Marketing Network and Informatization Construction Project15,484.6013,184.6014,500.003,500.00Partially completed
Supplementation of Working Capital15,000.0015,000.0015,000.0013,804.93Completed
Total74,374.6295,062.1254,000.0052,804.93

Unit: Ten Thousand Yuan

II. Termination of Raised Capital Projects and Remaining Raised Capital

(I) Termination of Raised Capital Projects and Remaining Raised Capital

As of July 28, 2026, the utilization and surplus of raised capital are as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.